Indacaterol/glycopyrronium (IND/GLY) delays clinically important deterioration (CID) versus salmeterol/fluticasone (SFC) in symptomatic COPD patients: LANTERN/ILLUMINATE pooled analysis

  • Antonio R. Anzueto, Konstantinos Kostikas, Karen Mezzi, Sebastian Fucile, Giovanni Bader, Steven Shen, Donald Banerji, Robert Fogel
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.pa983

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1183/13993003.congress-2016.pa983

In partnership with:

Link to European Respiratory Society (ERS) showcase